Conclusion
SARS-CoV-2 infection can interfere with the immune system and its
balance; therefore, it may result in an increased risk of fungal
infections such as invasive candidiasis, pulmonary aspergillosis, and
PJP. In the current study, we presented a case of COVID-19 infection,
who was complicated with PJP, following treatment with rituximab for
RRMS. We hope this article helps clinicians consider causes other than
COVID-19, especially opportunistic infections such as PJP, in patients
with respiratory symptoms and fever.